Covered recipient · General Payments record
CATHERINE V WILLIAMS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$468.11
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.22 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $67.02 | 3 |
| ABBVIE INC. | $51.38 | 2 |
| Astellas Pharma US Inc | $38.55 | 2 |
| Amgen Inc. | $38.20 | 2 |
| Acerta Pharma LLC | $16.82 | 1 |
| GlaxoSmithKline, LLC. | $15.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.38 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108414501 | CMS |
| ABBVIE INC. | $25.00 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108414503 | CMS |
| Amgen Inc. | $18.63 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117718502 | CMS |
| Amgen Inc. | $19.57 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116209789 | CMS |
| Astellas Pharma US Inc | $20.63 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139486474 | CMS |
| Astellas Pharma US Inc | $17.92 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139543284 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.82 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104414137 | CMS |
| GlaxoSmithKline, LLC. | $15.25 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116700061 | CMS |
| Novo Nordisk Inc | $20.69 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100233404 | CMS |
| Novo Nordisk Inc | $23.58 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100253724 | CMS |
| Novo Nordisk Inc | $22.75 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100274978 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.